Access cutting-edge neurogenic bladder treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.
Access neurogenic bladder specialists in Philadelphia at no cost
This study follows strict safety protocols and ethical guidelines
All study-related neurogenic bladder treatment provided free
This is a first-in-human, Phase 1b/2a, open-label, dose-escalation study of a single treatment course consisting of multiple intradetrusor injections of EG110A in male and female adult participants with Neurogenic Detrusor Overactivity (NDO)-related incontinence following Spinal Cord Injury (SCI), who have persistent incontinence after standard of care therapy and who perform Clear Intermittent Catheterization (CIC) on a regular basis.
Sponsor: EG 427
Check if you qualify for this neurogenic bladder clinical trial in Philadelphia, PA
If you're searching for neurogenic bladder treatment options in Philadelphia, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neurogenic bladder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.